LIMES SCHLOSSKLINIKEN AG (LIK.DE) Stock Fundamental Analysis
Europe - Frankfurt Stock Exchange - FRA:LIK - DE000A0JDBC7 - Common Stock
338 EUR
-10 (-2.87%)
Taking everything into account, LIK scores 6 out of 10 in our fundamental rating. LIK was compared to 27 industry peers in the Health Care Providers & Services industry. LIK scores excellent points on both the profitability and health parts. This is a solid base for a good stock. LIK is not overvalued while it is showing excellent growth. This is an interesting combination. With these ratings, LIK could be worth investigating further for growth and quality investing!.
1. Profitability
1.1 Basic Checks
LIK had positive earnings in the past year.
Of the past 5 years LIK 4 years were profitable.
In multiple years LIK reported negative operating cash flow during the last 5 years.
1.2 Ratios
LIK has a Return On Assets of 10.51%. This is amongst the best in the industry. LIK outperforms 100.00% of its industry peers.
The Return On Equity of LIK (20.85%) is better than 96.30% of its industry peers.
With an excellent Return On Invested Capital value of 15.26%, LIK belongs to the best of the industry, outperforming 100.00% of the companies in the same industry.
Measured over the past 3 years, the Average Return On Invested Capital for LIK is significantly above the industry average of 6.91%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 10.51% | ||
| ROE | 20.85% | ||
| ROIC | 15.26% |
ROA(3y)11.35%
ROA(5y)9.91%
ROE(3y)25.76%
ROE(5y)22.78%
ROIC(3y)15.32%
ROIC(5y)N/A
1.3 Margins
Looking at the Profit Margin, with a value of 10.81%, LIK belongs to the top of the industry, outperforming 100.00% of the companies in the same industry.
In the last couple of years the Profit Margin of LIK has declined.
Looking at the Operating Margin, with a value of 16.42%, LIK belongs to the top of the industry, outperforming 100.00% of the companies in the same industry.
In the last couple of years the Operating Margin of LIK has declined.
Looking at the Gross Margin, with a value of 95.03%, LIK belongs to the top of the industry, outperforming 100.00% of the companies in the same industry.
In the last couple of years the Gross Margin of LIK has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 16.42% | ||
| PM (TTM) | 10.81% | ||
| GM | 95.03% |
OM growth 3Y-14.42%
OM growth 5YN/A
PM growth 3Y-19.47%
PM growth 5YN/A
GM growth 3Y-0.09%
GM growth 5Y-0.06%
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) well above the Cost of Capital (WACC), LIK is creating value.
LIK has about the same amout of shares outstanding than it did 1 year ago.
The number of shares outstanding for LIK remains at a similar level compared to 5 years ago.
The debt/assets ratio for LIK has been reduced compared to a year ago.
2.2 Solvency
An Altman-Z score of 5.06 indicates that LIK is not in any danger for bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 5.06, LIK belongs to the top of the industry, outperforming 96.30% of the companies in the same industry.
A Debt/Equity ratio of 0.56 indicates that LIK is somewhat dependend on debt financing.
The Debt to Equity ratio of LIK (0.56) is better than 81.48% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.56 | ||
| Debt/FCF | N/A | ||
| Altman-Z | 5.06 |
ROIC/WACC2.22
WACC6.86%
2.3 Liquidity
A Current Ratio of 3.25 indicates that LIK has no problem at all paying its short term obligations.
The Current ratio of LIK (3.25) is better than 100.00% of its industry peers.
LIK has a Quick Ratio of 3.23. This indicates that LIK is financially healthy and has no problem in meeting its short term obligations.
The Quick ratio of LIK (3.23) is better than 100.00% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 3.25 | ||
| Quick Ratio | 3.23 |
3. Growth
3.1 Past
The Earnings Per Share has been growing slightly by 6.76% over the past year.
Measured over the past years, LIK shows a decrease in Earnings Per Share. The EPS has been decreasing by -7.60% on average per year.
LIK shows a decrease in Revenue. In the last year, the revenue decreased by -0.13%.
Measured over the past years, LIK shows a very strong growth in Revenue. The Revenue has been growing by 35.58% on average per year.
EPS 1Y (TTM)6.76%
EPS 3Y-7.6%
EPS 5YN/A
EPS Q2Q%81.09%
Revenue 1Y (TTM)-0.13%
Revenue growth 3Y14.74%
Revenue growth 5Y35.58%
Sales Q2Q%23.74%
3.2 Future
The Earnings Per Share is expected to grow by 36.77% on average over the next years. This is a very strong growth
The Revenue is expected to grow by 23.59% on average over the next years. This is a very strong growth
EPS Next Y55.18%
EPS Next 2Y36.77%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year29.32%
Revenue Next 2Y23.59%
Revenue Next 3YN/A
Revenue Next 5YN/A
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
4. Valuation
4.1 Price/Earnings Ratio
A Price/Earnings ratio of 21.57 indicates a rather expensive valuation of LIK.
The rest of the industry has a similar Price/Earnings ratio as LIK.
Compared to an average S&P500 Price/Earnings ratio of 25.98, LIK is valued at the same level.
The Price/Forward Earnings ratio is 10.20, which indicates a very decent valuation of LIK.
LIK's Price/Forward Earnings ratio is rather cheap when compared to the industry. LIK is cheaper than 81.48% of the companies in the same industry.
The average S&P500 Price/Forward Earnings ratio is at 35.79. LIK is valued rather cheaply when compared to this.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 21.57 | ||
| Fwd PE | 10.2 |
4.2 Price Multiples
LIK's Enterprise Value to EBITDA ratio is in line with the industry average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | 10.18 |
4.3 Compensation for Growth
LIK's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
The decent profitability rating of LIK may justify a higher PE ratio.
A more expensive valuation may be justified as LIK's earnings are expected to grow with 36.77% in the coming years.
PEG (NY)0.39
PEG (5Y)N/A
EPS Next 2Y36.77%
EPS Next 3YN/A
5. Dividend
5.1 Amount
LIK does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
FRA:LIK (11/24/2025, 7:00:00 PM)
338
-10 (-2.87%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)
Earnings (Next)
Inst Owners6.84%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap98.02M
Revenue(TTM)42.54M
Net Income(TTM)4.60M
Analysts80
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 21.57 | ||
| Fwd PE | 10.2 | ||
| P/S | 2.3 | ||
| P/FCF | N/A | ||
| P/OCF | N/A | ||
| P/B | 4.45 | ||
| P/tB | 6.97 | ||
| EV/EBITDA | 10.18 |
EPS(TTM)15.67
EY4.64%
EPS(NY)33.14
Fwd EY9.81%
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS146.68
BVpS76.04
TBVpS48.46
PEG (NY)0.39
PEG (5Y)N/A
Graham Number163.73
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 10.51% | ||
| ROE | 20.85% | ||
| ROCE | 18.69% | ||
| ROIC | 15.26% | ||
| ROICexc | 21.72% | ||
| ROICexgc | 31.24% | ||
| OM | 16.42% | ||
| PM (TTM) | 10.81% | ||
| GM | 95.03% | ||
| FCFM | N/A |
ROA(3y)11.35%
ROA(5y)9.91%
ROE(3y)25.76%
ROE(5y)22.78%
ROIC(3y)15.32%
ROIC(5y)N/A
ROICexc(3y)23.25%
ROICexc(5y)N/A
ROICexgc(3y)57.5%
ROICexgc(5y)N/A
ROCE(3y)18.77%
ROCE(5y)N/A
ROICexgc growth 3Y-31.59%
ROICexgc growth 5YN/A
ROICexc growth 3Y-14.79%
ROICexc growth 5YN/A
OM growth 3Y-14.42%
OM growth 5YN/A
PM growth 3Y-19.47%
PM growth 5YN/A
GM growth 3Y-0.09%
GM growth 5Y-0.06%
F-ScoreN/A
Asset Turnover0.97
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.56 | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | 1.26 | ||
| Cap/Depr | N/A | ||
| Cap/Sales | N/A | ||
| Interest Coverage | N/A | ||
| Cash Conversion | N/A | ||
| Profit Quality | N/A | ||
| Current Ratio | 3.25 | ||
| Quick Ratio | 3.23 | ||
| Altman-Z | 5.06 |
F-ScoreN/A
WACC6.86%
ROIC/WACC2.22
Cap/Depr(3y)160.08%
Cap/Depr(5y)N/A
Cap/Sales(3y)11.64%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)6.76%
EPS 3Y-7.6%
EPS 5YN/A
EPS Q2Q%81.09%
EPS Next Y55.18%
EPS Next 2Y36.77%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-0.13%
Revenue growth 3Y14.74%
Revenue growth 5Y35.58%
Sales Q2Q%23.74%
Revenue Next Year29.32%
Revenue Next 2Y23.59%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y28.44%
EBIT growth 3Y-1.81%
EBIT growth 5YN/A
EBIT Next Year99.7%
EBIT Next 3Y40.47%
EBIT Next 5Y29.34%
FCF growth 1Y890.53%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y18.63%
OCF growth 3YN/A
OCF growth 5YN/A
LIMES SCHLOSSKLINIKEN AG / LIK.DE FAQ
What is the ChartMill fundamental rating of LIMES SCHLOSSKLINIKEN AG (LIK.DE) stock?
ChartMill assigns a fundamental rating of 6 / 10 to LIK.DE.
Can you provide the valuation status for LIMES SCHLOSSKLINIKEN AG?
ChartMill assigns a valuation rating of 5 / 10 to LIMES SCHLOSSKLINIKEN AG (LIK.DE). This can be considered as Fairly Valued.
How profitable is LIMES SCHLOSSKLINIKEN AG (LIK.DE) stock?
LIMES SCHLOSSKLINIKEN AG (LIK.DE) has a profitability rating of 7 / 10.
Can you provide the expected EPS growth for LIK stock?
The Earnings per Share (EPS) of LIMES SCHLOSSKLINIKEN AG (LIK.DE) is expected to grow by 55.18% in the next year.